The Food and Drug Administration (FDA) on Thursday approved a higher dose of the Wegovy weight loss drug. The manufacturer, Novo Nordisk, increased the semaglutide injection by 4.8 mg to total 7.2 mg. The company says the higher dosage is recommended for those who taken the lower dose already for at least four weeks. Novo Nordisk…
